Purpose Consolidation immunotherapy after completion of chemoradiotherapy has become the standard of care for unresectable locally advanced non-small cell lung cancer and can induce potentially severe and life-threatening adverse events, including both immune checkpoint inhibitor-related pneumonitis (CIP) and radiation pneumonitis (RP), which are very challenging for radiologists to diagnose. Differentiating between CIP and RP has significant implications for clinical management such as the treatments to pneumonitis and the decision to continue or restart immunotherapy. The purpose of this study is to differentiate between CIP and RP by a CT radiomics approach. Methods We retrospectively collected the CT images and clinical information of p...
The differentiation of non-small cell lung cancer (NSCLC) and radiation pneumonitis (RP) is critical...
Abstract To predict grade ≥ 2 radiation pneumonitis (RP) in patients with locally advanced non-small...
BackgroundEnrichment of tumor-infiltrating lymphocytes (TIL) in the tumor microenvironment (TME) is ...
Introduction: Immunotherapy-induced pneumonitis (IIP) is a serious side-effect which requires accura...
BackgroundEnrichment of tumor-infiltrating lymphocytes (TIL) in the tumor microenvironment (TME) is ...
Improving outcomes for non-small-cell lung cancer patients treated with radiation therapy (RT) requi...
peer reviewedBACKGROUND AND PURPOSE: Radiation recall pneumonitis (RRP) is a delayed radiation-induc...
Purpose: Combined radiotherapy (RT) and immune checkpoint-inhibitor (ICI) therapy can act synergisti...
Abstract Background Pneumonitis is a potential consequence of both lung-directed radiation and immun...
Purpose: To develop a deep learning model that combines CT and radiation dose (RD) images to predict...
Purpose: Cancer treatments with immune checkpoint inhibitors (ICI) are associated with a unique set ...
Purpose: To assess the efficacy of radiomics features obtained by computed tomography (CT) examinati...
Purpose: To assess the efficacy of radiomics features obtained by computed tomography (CT) examinati...
In patients with primary or secondary lung tumour treated with immune checkpoint inhibitors, immune-...
BackgroundEnrichment of tumor-infiltrating lymphocytes (TIL) in the tumor microenvironment (TME) is ...
The differentiation of non-small cell lung cancer (NSCLC) and radiation pneumonitis (RP) is critical...
Abstract To predict grade ≥ 2 radiation pneumonitis (RP) in patients with locally advanced non-small...
BackgroundEnrichment of tumor-infiltrating lymphocytes (TIL) in the tumor microenvironment (TME) is ...
Introduction: Immunotherapy-induced pneumonitis (IIP) is a serious side-effect which requires accura...
BackgroundEnrichment of tumor-infiltrating lymphocytes (TIL) in the tumor microenvironment (TME) is ...
Improving outcomes for non-small-cell lung cancer patients treated with radiation therapy (RT) requi...
peer reviewedBACKGROUND AND PURPOSE: Radiation recall pneumonitis (RRP) is a delayed radiation-induc...
Purpose: Combined radiotherapy (RT) and immune checkpoint-inhibitor (ICI) therapy can act synergisti...
Abstract Background Pneumonitis is a potential consequence of both lung-directed radiation and immun...
Purpose: To develop a deep learning model that combines CT and radiation dose (RD) images to predict...
Purpose: Cancer treatments with immune checkpoint inhibitors (ICI) are associated with a unique set ...
Purpose: To assess the efficacy of radiomics features obtained by computed tomography (CT) examinati...
Purpose: To assess the efficacy of radiomics features obtained by computed tomography (CT) examinati...
In patients with primary or secondary lung tumour treated with immune checkpoint inhibitors, immune-...
BackgroundEnrichment of tumor-infiltrating lymphocytes (TIL) in the tumor microenvironment (TME) is ...
The differentiation of non-small cell lung cancer (NSCLC) and radiation pneumonitis (RP) is critical...
Abstract To predict grade ≥ 2 radiation pneumonitis (RP) in patients with locally advanced non-small...
BackgroundEnrichment of tumor-infiltrating lymphocytes (TIL) in the tumor microenvironment (TME) is ...